Skip to content
★ Sign in to follow
AB

Alon Ben-Noon

CEO
NeuroSense Therapeutics Ltd.
Insider activity · 24 months1 buy0 salesCumulative net flow
Total declarations
1
Company
1
▲ Purchases (1 ops.)
€172k
▼ Sales (0 ops.)
—

Latest filing published 17 Jun 2026 for NeuroSense Therapeutics Ltd., €172k.

Filing timeline

BuySale
Alon Ben-Noon

Insider track record

Disclosed buys
1
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Alon Ben-Noon: trading record in brief

One trade, one date: on 17 June 2026, Alon Ben-Noon disclosed an open-market purchase of €172k in NeuroSense Therapeutics Ltd. No broader history exists yet. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Alon Ben-Noon

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations1 total
  • ▲
    Chief Executive OfficerExecutivesNeuroSense Therapeutics Ltd.
    200,000 USD30SEC
    250,000 shares@ US$0.80100.0% of flowOrdinary SharesSEC:0001213900-26-069663:0
    Canonical exit: 14 Sept 2026 (T+90)

1 of 1 declaration